Related Experiment Video
Updated: Aug 6, 2026

Measuring Post-Stroke Cerebral Edema, Infarct Zone and Blood-Brain Barrier Breakdown in a Single Set of Rodent Brain Samples
Published on: October 23, 2020
[Specific markers of myocardial injury in acute stroke]
A B Guerrero-Peral1, A L Guerrero-Peral, Y Carrascal
1Servicio de Análisis Clínicos. Hospital Universitario de Valladolid. Valladolid, España. aguerrerop@medynet.com
Insights
New biochemical markers like troponin T and troponin I detect myocardial damage in acute cerebrovascular disease (ACVD) more effectively than traditional methods, correlating with patient mortality.
Area of Science:
- Cardiology
- Neurology
- Biochemistry
Context:
- Acute damage to the central nervous system, particularly acute cerebrovascular disease (ACVD), is linked to myocardial lesions.
- Traditional diagnostic markers may not fully capture this cardiac involvement.
Purpose:
- To investigate the utility of novel biochemical markers (troponin T, troponin I, myoglobin) in identifying myocardial damage associated with ACVD.
- To compare the sensitivity of these new markers against conventional markers (CK, CK MB) and electrocardiographic changes.
Summary:
- A retrospective study analyzed 42 ACVD patients, assessing clinical, electrocardiographic, and biochemical variables.
- Newer markers (troponin T, troponin I, myoglobin) showed higher positivity rates for myocardial damage compared to CK, CK MB, and ECG findings.
- Positivity and levels of troponin T and troponin I correlated with patient mortality.
Impact:
- This study introduces novel biochemical markers for myocardial damage in ACVD to the Spanish scientific literature.
- Findings suggest these markers are more sensitive in detecting cardiac injury post-stroke.
- Further research with larger cohorts is recommended to refine therapeutic strategies and understand lesion-specific risks.
Introduction:
It is thought that any acute damage to the central nervous system and, more particularly, acute cerebrovascular disease (ACVD) can give rise to a myocardial lesion. Our aim is to apply the latest biochemical markers (troponin T, troponin I and myoglobin) to the study of this problem.
Patients And Methods:
We conducted a retrospective study of 42 patients who were consecutively admitted to hospital with ACVD. The pathological antecedents and the clinical and electrocardiographic variables were considered in each case. A single determination of CK, CK MB, myoglobin, troponin T and troponin I was performed for each patient.
Results:
The determination of the new biochemical markers was positive in a higher number of cases than CK and its MB fraction, or electrocardiographic alterations. This positivity, together with the troponin T and troponin I values correlate with mortality.
Conclusions:
We present the first research work to be published in Spanish that studies the new biochemical markers of myocardial damage in ACVD. We urge researchers to carry out further analyses on more extensive series in order to determine the influence myocardial damage has on mortality and to establish suitable therapeutic measures. This will also allow us to find out whether a certain location or size of the lesion can give rise to a higher predisposition to this kind of damage
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Stroke ll: Pathophysiology

